NCT02073136

Brief Summary

Patients with chronic kidney disease struggle to eliminate phosphate as the renal function deteriorates, which results in accumulation of phosphate in the body. This has been shown to increase the patients' risk of cardiovascular disease and death. Even with dialysis treatment the patients cannot excrete enough phosphate to reach phosphate balance. The patients are therefore recommended a very restrictive diet when they reach the dialysis stage. It is therefore important to find ways to prevent such accumulation of phosphate in the body as early in the disease process as possible, but without compromising the nutritional status. Because phosphate occurs naturally in many of our foods, such as meat, fish and dairy products, it is difficult to reduce the intake of phosphate, without also reducing the intake of energy and protein. Over the past couple of years there has been an increased focus on the use of phosphate containing additives in the food industry. A reduction in the intake of phosphorus containing additives may reduce the accumulation of phosphate in the body. This can be achieved by decreasing the intake of processed food products. Because it is also very time consuming and inconvenient for the patient to keep these strict diets, the patients have a reasonable claim to know which effects can be achieved by such diets. This will therefore seek to be further explored in the following study. The study is conducted as a randomised crossover trial in predialysis patients stage 3-4.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 27, 2014

Completed
2 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

July 18, 2014

Status Verified

July 1, 2014

Enrollment Period

4 months

First QC Date

February 25, 2014

Last Update Submit

July 17, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Phosphate balance

    1 week

Secondary Outcomes (7)

  • p-phosphate

    1 week

  • p-PTH

    1 week

  • p-Calcium

    1 week

  • FGF23

    1 week

  • p-25(OH)D

    1 week

  • +2 more secondary outcomes

Study Arms (1)

Phosphate modified diet

EXPERIMENTAL
Other: Diet with phosphate containing additivesOther: Diet without phosphate containing additives

Interventions

Phosphate modified diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients \> 18 years.
  • Diagnosed with Chronic Kidney Disease stage 3-4 (GFR 15-59 ml / min)
  • p-phosphate between 0.85 mmol / L (2.7 mg / dL) and 1.50 mmol / L (4.7 mg / dl)
  • Read and understand Danish
  • Have received oral and written information about the study
  • Signed informed consent form

You may not qualify if:

  • Diagnosed hyperphosphatemia
  • Diagnosed hyperparathyroidism
  • Treatment with phosphate binders
  • Dysphagia
  • Diagnosed with decreased absorption capacity in the intestine
  • Co-morbidities in liver, pancreas or lungs
  • Dementia
  • Pregnancy / breastfeeding
  • Embedded within the last 4 weeks
  • Kidney transplant
  • Terminal patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herlev Hospital

Herlev, Herlev Ringvej 75, 2730, Denmark

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Diet

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Jens R Andersen, MD, MPA

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor at the University of Copenhagen

Study Record Dates

First Submitted

February 25, 2014

First Posted

February 27, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

July 18, 2014

Record last verified: 2014-07

Locations